PepGen

PEPG · NASDAQ

$2.87+$0.17 (+6.30%)TodayMarket closed · Oct 20, 7:52 PM ET

Prev close $2.70

Latest news

NewsSep 8, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseAug 6, 7:32 AM ETBusiness Wire
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseAug 6, 7:30 AM ETBusiness Wire
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
Press releaseMay 21, 7:00 AM ETBusiness Wire
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
Press releaseMay 12, 4:05 PM ETBusiness Wire
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseApr 30, 10:40 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseApr 28, 5:19 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseApr 14, 5:15 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseApr 7, 4:57 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseApr 2, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NewsMar 31, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMar 31, 12:07 PM ETAvi Kapoor
Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook
NewsMar 31, 9:42 AM ETAvi Kapoor
Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings
NewsMar 31, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMar 31, 7:14 AM ETVandana Singh
Why Is PepGen Stock Sinking Tuesday?
NewsMar 31, 4:50 AM ETAvi Kapoor
Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
NewsMar 30, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseMar 30, 4:05 PM ETBusiness Wire
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
Press releaseMar 26, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseMar 17, 5:28 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseMar 12, 6:30 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Press releaseMar 5, 8:00 PM ETGlobe Newswire
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
NewsMar 5, 8:02 AM ETAvi Kapoor
Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsMar 5, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMar 5, 5:01 AM ETAvi Kapoor
Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
NewsMar 5, 4:30 AM ETVandana Singh
FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial
NewsMar 4, 4:13 PM ET
PepGen Inc. FREEDOM2 Trial Placed On Partial FDA Hold Related To Preclinical Pharmacology And Toxicology; Cleared To Proceed In South Korea, Australia, And New Zealand And Dosing Of The 10 mg/kg Cohort Continues In The UK And Canada; Data Expected In 2026
Press releaseMar 4, 4:05 PM ETBusiness Wire
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
Press releaseMar 4, 4:03 PM ETBusiness Wire
PepGen Announces Regulatory Updates on FREEDOM2
Press releaseMar 3, 7:00 AM ETBusiness Wire
PepGen to Participate in the Leerink Global Healthcare Conference
NewsDec 11, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseDec 9, 7:00 AM ETBusiness Wire
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
Press releaseDec 8, 7:00 AM ETBusiness Wire
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
Press releaseNov 12, 7:05 AM ETBusiness Wire
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
Press releaseNov 12, 7:00 AM ETBusiness Wire
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseNov 3, 7:00 AM ETBusiness Wire
PepGen to Participate in Upcoming Investor Conferences
Press releaseOct 2, 7:00 AM ETBusiness Wire
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Tuesday's After-Market Session

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook

Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Is PepGen Stock Sinking Tuesday?

Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's After-Market Session

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial

PepGen Inc. FREEDOM2 Trial Placed On Partial FDA Hold Related To Preclinical Pharmacology And Toxicology; Cleared To Proceed In South Korea, Australia, And New Zealand And Dosing Of The 10 mg/kg Cohort Continues In The UK And Canada; Data Expected In 2026

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

PepGen Announces Regulatory Updates on FREEDOM2

PepGen to Participate in the Leerink Global Healthcare Conference

12 Health Care Stocks Moving In Thursday's After-Market Session

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen to Participate in Upcoming Investor Conferences

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society